Atlas Trials

Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease

Clinical trial NCT05894343 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05894343
Sponsor
MeiraGTx, LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2023-05-19
Primary completion
2029-10-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.